The DOI matches its Crossref record; 204 of the 204 references it cites were found in a registry or an index.
EASL Recommendations on Treatment of Hepatitis C 2018
Open accessAbstract
Summary Hepatitis C virus (HCV) infection is a major cause of chronic liver disease, with approximately 71 million chronically infected individuals worldwide. Clinical care for patients with HCV-related liver disease has advanced considerably thanks to an enhanced understanding of the pathophysiology of the disease, and because of developments in diagnostic procedures and improvements in therapy and prevention. These European Association for the Study of the Liver Recommendations on Treatment of Hepatitis C describe the optimal management of patients with acute and chronic HCV infections in 2018 and onwards.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus Infection
Fried, M. W., Shiffman, M. L., Reddy, K. R., Smith, C., Marinos, G., Gonçales, F. L., Häussinger, D., Diago, M., Carosi, G., Dhumeaux, D., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020047 · Cited by 6,389
Manns, M. P., McHutchison, J. G., Gordon, S. C., Rustgi, V. K., Shiffman, M., Reindollar, R., Goodman, Z. D., Koury, K., Ling, M.-H., & Albrecht, J. K. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06102-5 · Cited by 6,029
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
Lampertico, P., Agarwal, K., Berg, T., Buti, M., Janssen, H. L. A., Papatheodoridis, G., Zoulim, F., & Tacke, F. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.03.021 · Cited by 5,391
Hadziyannis, S. J., Sette, H., Morgan, T. R., Balan, V., Diago, M., Marcellin, P., Ramadori, G., Bodenheimer, H., Bernstein, D., Rizzetto, M., et al. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-140-5-200403020-00010 · Cited by 2,836
Global epidemiology of hepatitis C virus infection
Shepard, C. W., Finelli, L., & Alter, M. J. (2005) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(05)70216-4 · Cited by 2,758
Perz, J. F., Armstrong, G. L., Farrington, L. A., Hutin, Y. J. F., & Bell, B. P. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2006.05.013 · Cited by 2,572
Boceprevir for Untreated Chronic HCV Genotype 1 Infection
Poordad, F., McCone, J., Bacon, B. R., Bruno, S., Manns, M. P., Sulkowski, M. S., Jacobson, I. M., Reddy, K. R., Goodman, Z. D., Boparai, N., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1010494 · Cited by 2,520
Castéra, L., Vergniol, J., Foucher, J., Le Bail, B., Chanteloup, E., Haaser, M., Darriet, M., Couzigou, P., & de Lédinghen, V. (2005) · Gastroenterology · doi:10.1053/j.gastro.2004.11.018 · Cited by 2,487
Telaprevir for Previously Untreated Chronic Hepatitis C Virus Infection
Jacobson, I. M., McHutchison, J. G., Dusheiko, G., Di Bisceglie, A. M., Reddy, K. R., Bzowej, N. H., Marcellin, P., Muir, A. J., Ferenci, P., Flisiak, R., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1012912 · Cited by 2,398
Self-citationBlach, S., Zeuzem, S., Manns, M., Altraif, I., Duberg, A.-S., Muljono, D. H., Waked, I., Alavian, S. M., Lee, M.-H., Negro, F., et al. (2017) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(16)30181-9 · Cited by 2,006
Self-citation(2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.04.006 · Cited by 1,875
Sofosbuvir for Previously Untreated Chronic Hepatitis C Infection
Lawitz, E., Mangia, A., Wyles, D., Rodriguez-Torres, M., Hassanein, T., Gordon, S. C., Schultz, M., Davis, M. N., Kayali, Z., Reddy, K. R., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1214853 · Cited by 1,788
Diagnosis, management, and treatment of hepatitis C†
Strader, D. B., Wright, T., Thomas, D. L., & Seeff, L. B. (2004) · Hepatology · doi:10.1002/hep.20119 · Cited by 1,709
Ledipasvir and Sofosbuvir for Untreated HCV Genotype 1 Infection
Afdhal, N., Zeuzem, S., Kwo, P., Chojkier, M., Gitlin, N., Puoti, M., Romero-Gomez, M., Zarski, J.-P., Agarwal, K., Buggisch, P., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1402454 · Cited by 1,705
Self-citationBoceprevir for Previously Treated Chronic HCV Genotype 1 Infection
Bacon, B. R., Gordon, S. C., Lawitz, E., Marcellin, P., Vierling, J. M., Zeuzem, S., Poordad, F., Goodman, Z. D., Sings, H. L., Boparai, N., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1009482 · Cited by 1,626
Telaprevir for Retreatment of HCV Infection
Zeuzem, S., Andreone, P., Pol, S., Lawitz, E., Diago, M., Roberts, S., Focaccia, R., Younossi, Z., Foster, G. R., Horban, A., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1013086 · Cited by 1,546
van der Meer, A. J., Veldt, B. J., Feld, J. J., Wedemeyer, H., Dufour, J.-F., Lammert, F., Duarte-Rojo, A., Heathcote, E. J., Manns, M. P., Kuske, L., et al. (2012) · JAMA · doi:10.1001/jama.2012.144878 · Cited by 1,510
Self-citationDegenhardt, L., Peacock, A., Colledge, S., Leung, J., Grebely, J., Vickerman, P., Stone, J., Cunningham, E. B., Trickey, A., Dumchev, K., et al. (2017) · The Lancet Global Health · doi:10.1016/s2214-109x(17)30375-3 · Cited by 1,429
Andrews, J., Guyatt, G., Oxman, A. D., Alderson, P., Dahm, P., Falck-Ytter, Y., Nasser, M., Meerpohl, J., Post, P. N., Kunz, R., et al. (2013) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2012.03.013 · Cited by 1,416
Evolving epidemiology of hepatitis C virus
Lavanchy, D. (2011) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2010.03432.x · Cited by 1,318
Ledipasvir and Sofosbuvir for Previously Treated HCV Genotype 1 Infection
Afdhal, N., Reddy, K. R., Nelson, D. R., Lawitz, E., Gordon, S. C., Schiff, E., Nahass, R., Ghalib, R., Gitlin, N., Herring, R., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1316366 · Cited by 1,307
Nelson, P. K., Mathers, B. M., Cowie, B., Hagan, H., Des Jarlais, D., Horyniak, D., & Degenhardt, L. (2011) · The Lancet · doi:10.1016/s0140-6736(11)61097-0 · Cited by 1,267
Daclatasvir plus Sofosbuvir for Previously Treated or Untreated Chronic HCV Infection
Sulkowski, M. S., Gardiner, D. F., Rodriguez-Torres, M., Reddy, K. R., Hassanein, T., Jacobson, I., Lawitz, E., Lok, A. S., Hinestrosa, F., Thuluvath, P. J., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1306218 · Cited by 1,190
EASL Recommendations on Treatment of Hepatitis C 2015
(2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.03.025 · Cited by 1,156
Ledipasvir and Sofosbuvir for 8 or 12 Weeks for Chronic HCV without Cirrhosis
Kowdley, K. V., Gordon, S. C., Reddy, K. R., Rossaro, L., Bernstein, D. E., Lawitz, E., Shiffman, M. L., Schiff, E., Ghalib, R., Ryan, M., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1402355 · Cited by 1,130
Sofosbuvir and Velpatasvir for HCV Genotype 1, 2, 4, 5, and 6 Infection
Feld, J. J., Jacobson, I. M., Hézode, C., Asselah, T., Ruane, P. J., Gruener, N., Abergel, A., Mangia, A., Lai, C.-L., Chan, H. L. Y., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1512610 · Cited by 1,106
Sofosbuvir for Hepatitis C Genotype 2 or 3 in Patients without Treatment Options
Jacobson, I. M., Gordon, S. C., Kowdley, K. V., Yoshida, E. M., Rodriguez-Torres, M., Sulkowski, M. S., Shiffman, M. L., Lawitz, E., Everson, G., Bennett, M., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1214854 · Cited by 1,090
EASL Clinical Practice Guidelines: Management of hepatitis C virus infection
(2011) · Journal of Hepatology · doi:10.1016/j.jhep.2011.02.023 · Cited by 1,088
Orens, J. B., Estenne, M., Arcasoy, S., Conte, J. V., Corris, P., Egan, J. J., Egan, T., Keshavjee, S., Knoop, C., Kotloff, R., et al. (2006) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2006.03.011 · Cited by 1,073
The association between hepatitis C infection and survival after orthotopic liver transplantation
Forman, L. M., Lewis, J. D., Berlin, J. A., Feldman, H. I., & Lucey, M. R. (2002) · Gastroenterology · doi:10.1053/gast.2002.32418 · Cited by 1,031
Reig, M., Mariño, Z., Perelló, C., Iñarrairaegui, M., Ribeiro, A., Lens, S., Díaz, A., Vilana, R., Darnell, A., Varela, M., et al. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.04.008 · Cited by 1,018
EASL Recommendations on Treatment of Hepatitis C 2016
(2017) · Journal of Hepatology · doi:10.1016/j.jhep.2016.09.001 · Cited by 985
Conti, F., Buonfiglioli, F., Scuteri, A., Crespi, C., Bolondi, L., Caraceni, P., Foschi, F. G., Lenzi, M., Mazzella, G., Verucchi, G., et al. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.06.015 · Cited by 897
Micallef, J. M., Kaldor, J. M., & Dore, G. J. (2006) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2005.00651.x · Cited by 871
EASL Clinical Practice Guidelines: Management of hepatitis C virus infection
(2014) · Journal of Hepatology · doi:10.1016/j.jhep.2013.11.003 · Cited by 855
Sofosbuvir and Velpatasvir for HCV Genotype 2 and 3 Infection
Foster, G. R., Afdhal, N., Roberts, S. K., Bräu, N., Gane, E. J., Pianko, S., Lawitz, E., Thompson, A., Shiffman, M. L., Cooper, C., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1512612 · Cited by 846
Morgan, R. L., Baack, B., Smith, B. D., Yartel, A., Pitasi, M., & Falck-Ytter, Y. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-158-5-201303050-00005 · Cited by 829
Sofosbuvir and Velpatasvir for HCV in Patients with Decompensated Cirrhosis
Curry, M. P., O’Leary, J. G., Bzowej, N., Muir, A. J., Korenblat, K. M., Fenkel, J. M., Reddy, K. R., Lawitz, E., Flamm, S. L., Schiano, T., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1512614 · Cited by 804
Charlton, M., Everson, G. T., Flamm, S. L., Kumar, P., Landis, C., Brown, R. S., Fried, M. W., Terrault, N. A., O'Leary, J. G., Vargas, H. E., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.05.010 · Cited by 802
Nucleotide Polymerase Inhibitor Sofosbuvir plus Ribavirin for Hepatitis C
Gane, E. J., Stedman, C. A., Hyland, R. H., Ding, X., Svarovskaia, E., Symonds, W. T., Hindes, R. G., & Berrey, M. M. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1208953 · Cited by 764
HCV-related fibrosis progression following liver transplantation: increase in recent years
Berenguer, M., Ferrell, L., Watson, J., Prieto, M., Kim, M., Rayón, M., Córdoba, J., Herola, A., Ascher, N., Mir, J., et al. (2000) · Journal of Hepatology · doi:10.1016/s0168-8278(00)80231-7 · Cited by 748
Self-citationTakaki, A., Wiese, M., Maertens, G., Depla, E., Seifert, U., Liebetrau, A., Miller, J. L., Manns, M. P., & Rehermann, B. (2000) · Nature Medicine · doi:10.1038/75063 · Cited by 739
Side effects of therapy of hepatitis C and their management
Fried, M. W. (2002) · Hepatology · doi:10.1053/jhep.2002.36810 · Cited by 727
Zibbell, J. E., Asher, A. K., Patel, R. C., Kupronis, B., Iqbal, K., Ward, J. W., & Holtzman, D. (2018) · American Journal of Public Health · doi:10.2105/ajph.2017.304132 · Cited by 698
ABT-450/r–Ombitasvir and Dasabuvir with or without Ribavirin for HCV
Ferenci, P., Bernstein, D., Lalezari, J., Cohen, D., Luo, Y., Cooper, C., Tam, E., Marinho, R. T., Tsai, N., Nyberg, A., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1402338 · Cited by 693
Roth, D., Nelson, D. R., Bruchfeld, A., Liapakis, A., Silva, M., Monsour, H., Martin, P., Pol, S., Londoño, M.-C., Hassanein, T., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(15)00349-9 · Cited by 671
Extrahepatic manifestations of chronic hepatitis C
Cacoub, P., Poynard, T., Ghillani, P., Charlotte, F., Olivi, M., Charles Piette, J., Opolon, P., & for the MULTIVIRC GROUP (1999) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199910)42:10<2204::aid-anr24>3.0.co;2-d · Cited by 648
Williams, R., Aspinall, R., Bellis, M., Camps-Walsh, G., Cramp, M., Dhawan, A., Ferguson, J., Forton, D., Foster, G., Gilmore, S. I., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(14)61838-9 · Cited by 602
International guidelines for the selection of lung transplant candidates
Maurer, J. R., Frost, A. E., Estenne, M., Higenbottam, T., & Glanville, A. R. (1998) · Transplantation · doi:10.1097/00007890-199810150-00033 · Cited by 562
Sofosbuvir, Velpatasvir, and Voxilaprevir for Previously Treated HCV Infection
Bourlière, M., Gordon, S. C., Flamm, S. L., Cooper, C. L., Ramji, A., Tong, M., Ravendhran, N., Vierling, J. M., Tran, T. T., Pianko, S., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1613512 · Cited by 557
Side effects of therapy of hepatitis C and their management
Fried, M. W. (2002) · Hepatology · doi:10.1002/hep.1840360730 · Cited by 556
Nahon, P., Bourcier, V., Layese, R., Audureau, E., Cagnot, C., Marcellin, P., Guyader, D., Fontaine, H., Larrey, D., De Lédinghen, V., et al. (2017) · Gastroenterology · doi:10.1053/j.gastro.2016.09.009 · Cited by 538
Prieto, M., Berenguer, M., Rayón, J. M., Córdoba, J., Argüello, L., Carrasco, D., García-Herola, A., Olaso, V., De Juan, M., Gobernado, M., et al. (1999) · Hepatology · doi:10.1002/hep.510290122 · Cited by 537
Self-citationGerlach, J. T., Diepolder, H. M., Zachoval, R., Gruener, N. H., Jung, M.-C., Ulsenheimer, A., Schraut, W. W., Schirren, C. A., Waechtler, M., Backmund, M., et al. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00668-1 · Cited by 524
Hepatitis C Virus Resistance to Direct-Acting Antiviral Drugs in Interferon-Free Regimens
Pawlotsky, J.-M. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.04.003 · Cited by 519
Self-citationZeuzem, S., Ghalib, R., Reddy, K. R., Pockros, P. J., Ari, Z. B., Zhao, Y., Brown, D. D., Wan, S., DiNubile, M. J., Nguyen, B.-Y., et al. (2015) · Annals of Internal Medicine · doi:10.7326/m15-0785 · Cited by 516
Hepatitis C virus kinetics during and immediately after liver transplantation
Garcia-Retortillo, M., Forns, X., Feliu, A., Moitinho, E., Costa, J., Navasa, M., Rimola, A., & Rodes, J. (2002) · Hepatology · doi:10.1053/jhep.2002.31773 · Cited by 503
Waziry, R., Hajarizadeh, B., Grebely, J., Amin, J., Law, M., Danta, M., George, J., & Dore, G. J. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.07.025 · Cited by 500
Foster, G. R., Irving, W. L., Cheung, M. C. M., Walker, A. J., Hudson, B. E., Verma, S., McLauchlan, J., Mutimer, D. J., Brown, A., Gelson, W. T. H., et al. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.01.029 · Cited by 492
Martin, N. K., Vickerman, P., Grebely, J., Hellard, M., Hutchinson, S. J., Lima, V. D., Foster, G. R., Dillon, J. F., Goldberg, D. J., Dore, G. J., et al. (2013) · Hepatology · doi:10.1002/hep.26431 · Cited by 488
Ledipasvir and Sofosbuvir for HCV in Patients Coinfected with HIV-1
Naggie, S., Cooper, C., Saag, M., Workowski, K., Ruane, P., Towner, W. J., Marks, K., Luetkemeyer, A., Baden, R. P., Sax, P. E., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1501315 · Cited by 470
Herrmann, E., de Lédinghen, V., Cassinotto, C., Chu, W. C. ‐., Leung, V. Y. ‐., Ferraioli, G., Filice, C., Castera, L., Vilgrain, V., Ronot, M., et al. (2018) · Hepatology · doi:10.1002/hep.29179 · Cited by 468
Poordad, F., Schiff, E. R., Vierling, J. M., Landis, C., Fontana, R. J., Yang, R., McPhee, F., Hughes, E. A., Noviello, S., & Swenson, E. S. (2016) · Hepatology · doi:10.1002/hep.28446 · Cited by 460
Manns, M., Samuel, D., Gane, E. J., Mutimer, D., McCaughan, G., Buti, M., Prieto, M., Calleja, J. L., Peck-Radosavljevic, M., Müllhaupt, B., et al. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(16)00052-9 · Cited by 451
Glecaprevir–Pibrentasvir for 8 or 12 Weeks in HCV Genotype 1 or 3 Infection
Zeuzem, S., Foster, G. R., Wang, S., Asatryan, A., Gane, E., Feld, J. J., Asselah, T., Bourlière, M., Ruane, P. J., Wedemeyer, H., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1702417 · Cited by 439
Self-citationDegos, F., Perez, P., Roche, B., Mahmoudi, A., Asselineau, J., Voitot, H., & Bedossa, P. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.05.035 · Cited by 435
Larney, S., Peacock, A., Leung, J., Colledge, S., Hickman, M., Vickerman, P., Grebely, J., Dumchev, K. V., Griffiths, P., Hines, L., et al. (2017) · The Lancet Global Health · doi:10.1016/s2214-109x(17)30373-x · Cited by 422
(2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.05.045 · Cited by 419
Cheung, M. C. M., Walker, A. J., Hudson, B. E., Verma, S., McLauchlan, J., Mutimer, D. J., Brown, A., Gelson, W. T. H., MacDonald, D. C., Agarwal, K., et al. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.06.019 · Cited by 408
Glecaprevir and Pibrentasvir in Patients with HCV and Severe Renal Impairment
Gane, E., Lawitz, E., Pugatch, D., Papatheodoridis, G., Bräu, N., Brown, A., Pol, S., Leroy, V., Persico, M., Moreno, C., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1704053 · Cited by 400
Chou, R., & Wasson, N. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-158-11-201306040-00005 · Cited by 370
Andreone, P., Colombo, M. G., Enejosa, J. V., Koksal, I., Ferenci, P., Maieron, A., Müllhaupt, B., Horsmans, Y., Weiland, O., Reesink, H. W., et al. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.04.045 · Cited by 365
Singal, A. G., Volk, M. L., Jensen, D., Di Bisceglie, A. M., & Schoenfeld, P. S. (2010) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2009.11.018 · Cited by 362
Extrahepatic Morbidity and Mortality of Chronic Hepatitis C
Negro, F., Forton, D., Craxì, A., Sulkowski, M. S., Feld, J. J., & Manns, M. P. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.08.035 · Cited by 361
Self-citationDore, G. J., Altice, F., Litwin, A. H., Dalgard, O., Gane, E. J., Shibolet, O., Luetkemeyer, A., Nahass, R., Peng, C.-Y., Conway, B., et al. (2016) · Annals of Internal Medicine · doi:10.7326/m16-0816 · Cited by 359
Self-citationBelli, L. S., Berenguer, M., Cortesi, P. A., Strazzabosco, M., Rockenschaub, S.-R., Martini, S., Morelli, C., Donato, F., Volpes, R., Pageaux, G.-P., et al. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.05.010 · Cited by 343
Self-citationForns, X., Lee, S. S., Valdes, J., Lens, S., Ghalib, R., Aguilar, H., Felizarta, F., Hassanein, T., Hinrichsen, H., Rincon, D., et al. (2017) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(17)30496-6 · Cited by 343
Fibrosis progression after liver transplantation in patients with recurrent hepatitis C
Neumann, U. P., Berg, T., Bahra, M., Seehofer, D., Langrehr, J. M., Neuhaus, R., Radke, C., & Neuhaus, P. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2004.06.029 · Cited by 339
Swain, M. G., Lai, M., Shiffman, M. L., Cooksley, W. G. E., Zeuzem, S., Dieterich, D. T., Abergel, A., Pessôa, M. G., Lin, A., Tietz, A., et al. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.07.009 · Cited by 328
Martin, N. K., Hickman, M., Hutchinson, S. J., Goldberg, D. J., & Vickerman, P. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit296 · Cited by 314
Simmons, B., Saleem, J., Hill, A., Riley, R. D., & Cooke, G. S. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/civ948 · Cited by 314
Aspinall, E. J., Corson, S., Doyle, J. S., Grebely, J., Hutchinson, S. J., Dore, G. J., Goldberg, D. J., & Hellard, M. E. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit306 · Cited by 309
Rockstroh, J. K., Nelson, M., Katlama, C., Lalezari, J., Mallolas, J., Bloch, M., Matthews, G. V., Saag, M. S., Zamor, P. J., Orkin, C., et al. (2015) · The Lancet HIV · doi:10.1016/s2352-3018(15)00114-9 · Cited by 305
Degenhardt, L., Charlson, F., Stanaway, J., Larney, S., Alexander, L. T., Hickman, M., Cowie, B., Hall, W. D., Strang, J., Whiteford, H., et al. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(16)30325-5 · Cited by 305
Platt, L., Minozzi, S., Reed, J., Vickerman, P., Hagan, H., French, C., Jordan, A., Degenhardt, L., Hope, V., Hutchinson, S., et al. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012021.pub2 · Cited by 305
Kwo, P. Y., Poordad, F., Asatryan, A., Wang, S., Wyles, D. L., Hassanein, T., Felizarta, F., Sulkowski, M. S., Gane, E., Maliakkal, B., et al. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.03.039 · Cited by 302
Saxena, V., Koraishy, F. M., Sise, M. E., Lim, J. K., Schmidt, M., Chung, R. T., Liapakis, A., Nelson, D. R., Fried, M. W., Terrault, N. A., et al. (2016) · Liver International · doi:10.1111/liv.13102 · Cited by 300
Blasco, A., Forns, X., Carrión, J. A., García-Pagán, J. C., Gilabert, R., Rimola, A., Miquel, R., Bruguera, M., García-Valdecasas, J.-C., Bosch, J., et al. (2006) · Hepatology · doi:10.1002/hep.21090 · Cited by 293
Osinusi, A., Meissner, E. G., Lee, Y.-J., Bon, D., Heytens, L., Nelson, A., Sneller, M., Kohli, A., Barrett, L., Proschan, M., et al. (2013) · JAMA · doi:10.1001/jama.2013.109309 · Cited by 291
Grebely, J., Dalgard, O., Conway, B., Cunningham, E. B., Bruggmann, P., Hajarizadeh, B., Amin, J., Bruneau, J., Hellard, M., Litwin, A. H., et al. (2018) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(17)30404-1 · Cited by 291
Self-citationBerenguer, M., Palau, A., Aguilera, V., Rayón, J.-M., Juan, F. S., & Prieto, M. (2008) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2007.02126.x · Cited by 283
Self-citationPockros, P. J., Reddy, K. R., Mantry, P. S., Cohen, E., Bennett, M., Sulkowski, M. S., Bernstein, D. E., Cohen, D. E., Shulman, N. S., Wang, D., et al. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.02.078 · Cited by 278
Razavi, H., Robbins, S., Zeuzem, S., Negro, F., Buti, M., Duberg, A.-S., Roudot-Thoraval, F., Craxi, A., Manns, M., Marinho, R. T., et al. (2017) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(17)30045-6 · Cited by 267
Self-citationTreatment of hepatitis C virus–associated mixed cryoglobulinemia with direct‐acting antiviral agents
Sise, M. E., Bloom, A. K., Wisocky, J., Lin, M. V., Gustafson, J. L., Lundquist, A. L., Steele, D., Thiim, M., Williams, W. W., Hashemi, N., et al. (2016) · Hepatology · doi:10.1002/hep.28297 · Cited by 261
Reddy, K. R., Bourlière, M., Sulkowski, M., Omata, M., Zeuzem, S., Feld, J. J., Lawitz, E., Marcellin, P., Welzel, T. M., Hyland, R., et al. (2015) · Hepatology · doi:10.1002/hep.27826 · Cited by 255
Jacobson, I. M., Lawitz, E., Gane, E. J., Willems, B. E., Ruane, P. J., Nahass, R. G., Borgia, S. M., Shafran, S. D., Workowski, K. A., Pearlman, B., et al. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.03.047 · Cited by 239
Asselah, T., Kowdley, K. V., Zadeikis, N., Wang, S., Hassanein, T., Horsmans, Y., Colombo, M. G., Calinas, F., Aguilar, H. I., de Lédinghen, V., et al. (2017) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2017.09.027 · Cited by 233
Martin, N. K., Vickerman, P., Foster, G. R., Hutchinson, S. J., Goldberg, D. J., & Hickman, M. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2010.08.029 · Cited by 230
Wiessing, L., Ferri, M., Grady, B., Kantzanou, M., Sperle, I., Cullen, K. J., EMCDDA DRID group, Hatzakis, A., Prins, M., Vickerman, P., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0103345 · Cited by 224
Hagan, H., Pouget, E. R., Des Jarlais, D. C., & Lelutiu-Weinberger, C. (2008) · American Journal of Epidemiology · doi:10.1093/aje/kwn237 · Cited by 222
Kozbial, K., Moser, S., Schwarzer, R., Laferl, H., Al-Zoairy, R., Stauber, R., Stättermayer, A. F., Beinhardt, S., Graziadei, I., Freissmuth, C., et al. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.06.009 · Cited by 222
Cost–Effectiveness of Hepatitis C Virus Antiviral Treatment for Injection Drug User Populations
Martin, N. K., Vickerman, P., Miners, A., Foster, G. R., Hutchinson, S. J., Goldberg, D. J., & Hickman, M. (2012) · Hepatology · doi:10.1002/hep.24656 · Cited by 221
Terrault, N. A., Zeuzem, S., Di Bisceglie, A. M., Lim, J. K., Pockros, P. J., Frazier, L. M., Kuo, A., Lok, A. S., Shiffman, M. L., Ben Ari, Z., et al. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.08.004 · Cited by 219
Castéra, L., Sebastiani, G., Le Bail, B., de Lédinghen, V., Couzigou, P., & Alberti, A. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2009.11.008 · Cited by 214
Patient-physician role relationships and patient activation among individuals with chronic illness
Alexander, J. A., Hearld, L. R., Mittler, J. N., & Harvey, J. (2012) · Health Services Research · doi:10.1111/j.1475-6773.2011.01354.x · Cited by 206
Hofer, H., Watkins-Riedel, T., Janata, O., Penner, E., Holzmann, H., Steindl-Munda, P., Gangl, A., & Ferenci, P. (2003) · Hepatology · doi:10.1053/jhep.2003.50019 · Cited by 203
Afdhal, N. H., Bacon, B. R., Patel, K., Lawitz, E. J., Gordon, S. C., Nelson, D. R., Challies, T. L., Nasser, I., Garg, J., Wei, L.-J., et al. (2015) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2014.12.014 · Cited by 199
Wang, C., Ji, D., Chen, J., Shao, Q., Li, B., Liu, J., Wu, V., Wong, A., Wang, Y., Zhang, X., et al. (2017) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2016.06.023 · Cited by 199
Picciotto, F. P., Tritto, G., Lanza, A. G., Addario, L., De Luca, M., Di Costanzo, G., Lampasi, F., Tartaglione, M. T., Marsilia, G. M., Calise, F., et al. (2007) · Journal of Hepatology · doi:10.1016/j.jhep.2006.10.017 · Cited by 195
Arase, Y., Kobayashi, M., Suzuki, F., Suzuki, Y., Kawamura, Y., Akuta, N., Kobayashi, M., Sezaki, H., Saito, S., Hosaka, T., et al. (2013) · Hepatology · doi:10.1002/hep.26087 · Cited by 191
Balistreri, W. F., Murray, K. F., Rosenthal, P., Bansal, S., Lin, C., Kersey, K., Massetto, B., Zhu, Y., Kanwar, B., German, P., et al. (2017) · Hepatology · doi:10.1002/hep.28995 · Cited by 191
The neglected hepatitis C virus genotypes 4, 5 and 6: an international consensus report
Antaki, N., Craxi, A., Kamal, S., Moucari, R., Van der Merwe, S., Haffar, S., Gadano, A., Zein, N., Lai, C. L., Pawlotsky, J.-M., et al. (2010) · Liver International · doi:10.1111/j.1478-3231.2009.02188.x · Cited by 186
Self-citationBruggmann, P., & Litwin, A. H. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit271 · Cited by 184
HCV epidemiology in high-risk groups and the risk of reinfection
Midgard, H., Weir, A., Palmateer, N., Lo Re, V., Pineda, J. A., Macías, J., & Dalgard, O. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.07.012 · Cited by 183
Self-citationColombo, M., Aghemo, A., Liu, H., Zhang, J., Dvory-Sobol, H., Hyland, R., Yun, C., Massetto, B., Brainard, D. M., McHutchison, J. G., et al. (2017) · Annals of Internal Medicine · doi:10.7326/m16-1205 · Cited by 182
Self-citationAcute Hepatitis C: A Systematic Review.: CME
Kamal, S. M. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2008.01825.x · Cited by 180
Freiman, J. M., Tran, T. M., Schumacher, S. G., White, L. F., Ongarello, S., Cohn, J., Easterbrook, P. J., Linas, B. P., & Denkinger, C. M. (2016) · Annals of Internal Medicine · doi:10.7326/m16-0065 · Cited by 180
Arcaini, L., Besson, C., Frigeni, M., Fontaine, H., Goldaniga, M., Casato, M., Visentini, M., Torres, H. A., Loustaud-Ratti, V., Peveling-Oberhag, J., et al. (2016) · Blood · doi:10.1182/blood-2016-05-714667 · Cited by 179
Reversion of disease manifestations after HCV eradication
van der Meer, A. J., & Berenguer, M. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.07.039 · Cited by 178
Self-citationMartinot‐Peignoux, M., Stern, C., Maylin, S., Ripault, M., Boyer, N., Leclere, L., Castelnau, C., Giuily, N., El Ray, A., Cardoso, A., et al. (2010) · Hepatology · doi:10.1002/hep.23444 · Cited by 176
Management of chronic viral hepatitis before and after renal transplantation
Gane, E., & Pilmore, H. (2002) · Transplantation · doi:10.1097/00007890-200208270-00001 · Cited by 175
Laboratory Diagnostics for Hepatitis C Virus Infection
Kamili, S., Drobeniuc, J., Araujo, A. C., & Hayden, T. M. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis368 · Cited by 173
Kew, M. C., Yu, M.-C., Kedda, M., Coppin, A., Sarkin, A., & Hodkinson, J. (1997) · Gastroenterology · doi:10.1016/s0016-5085(97)70233-6 · Cited by 169
Li, D. K., Ren, Y., Fierer, D. S., Rutledge, S., Shaikh, O. S., Lo Re, V., Simon, T., Abou‐Samra, A., Chung, R. T., & Butt, A. A. (2018) · Hepatology · doi:10.1002/hep.29707 · Cited by 168
Saxena, V., Khungar, V., Verna, E. C., Levitsky, J., Brown, R. S., Hassan, M. A., Sulkowski, M. S., O'Leary, J. G., Koraishy, F., Galati, J. S., et al. (2017) · Hepatology · doi:10.1002/hep.29258 · Cited by 167
Alcohol Use and Treatment of Hepatitis C Virus: Results of a National Multicenter Study
Anand, B. S., Currie, S., Dieperink, E., Bini, E. J., Shen, H., Ho, S. B., & Wright, T. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.02.023 · Cited by 162
Cardoso, H., Vale, A. M., Rodrigues, S., Gonçalves, R., Albuquerque, A., Pereira, P., Lopes, S., Silva, M., Andrade, P., Morais, R., et al. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.07.027 · Cited by 162
Report of the Monothematic EASL Conference on Liver Transplantation for Viral Hepatitis
Samuel, D., Forns, X., Berenguer, M., Trautwein, C., Burroughs, A., Rizzetto, M., & Trepo, C. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2006.05.001 · Cited by 161
Self-citationWyles, D., Bräu, N., Kottilil, S., Daar, E. S., Ruane, P., Workowski, K., Luetkemeyer, A., Adeyemi, O., Kim, A. Y., Doehle, B., et al. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/cix260 · Cited by 161
Grebely, J., Lamoury, F. M. J., Hajarizadeh, B., Mowat, Y., Marshall, A. D., Bajis, S., Marks, P. S., Amin, J., Smith, J. R., Edwards, M., et al. (2017) · The Lancet. Gastroenterology & hepatology · doi:10.1016/s2468-1253(17)30075-4 · Cited by 161
Cabibbo, G., Petta, S., Calvaruso, V., Cacciola, I., Cannavò, M. R., Madonia, S., Distefano, M., Larocca, L., Prestileo, T., Tinè, F., et al. (2017) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.14256 · Cited by 161
Feld, J. J., Moreno, C., Trinh, R., Tam, E., Bourgeois, S., Horsmans, Y., Elkhashab, M., Bernstein, D. E., Younes, Z., Reindollar, R. W., et al. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2015.10.005 · Cited by 160
Page, K. A., Morris, M. D., Hahn, J. A., Maher, L., & Prins, M. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit300 · Cited by 157
Accuracy of Rapid and Point-of-Care Screening Tests for Hepatitis C
Shivkumar, S., Peeling, R. W. W., Jafari, Y., Joseph, L., & Pai, N. P. (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-157-8-201210160-00006 · Cited by 152
Rao, H., & Wei, L. (2011) · PubMed · Cited by 150
Hepatitis C Disease Burden in the United States in the era of oral direct‐acting antivirals
Chhatwal, J., Wang, X., Ayer, T., Kabiri, M., Chung, R. T., Hur, C., Donohue, J. M., Roberts, M. S., & Kanwal, F. (2016) · Hepatology · doi:10.1002/hep.28571 · Cited by 149
Read, P. J., Lothian, R., Chronister, K. J., Gilliver, R., Kearley, J., Dore, G. J., & van Beek, I. (2017) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2017.05.032 · Cited by 149
Rockstroh, J. K., Lacombe, K., Viani, R. M., Orkin, C. M., Wyles, D. L., Luetkemeyer, A. F., Soto-Malave, R., Flisiak, R., Bhagani, S. R., Sherman, K. E., et al. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy220 · Cited by 148
What Is Killing People with Hepatitis C Virus Infection?
Grebely, J., & Dore, G. J. (2011) · Seminars in Liver Disease · doi:10.1055/s-0031-1297922 · Cited by 145
Dried Blood Spot for Hepatitis C Virus Serology and Molecular Testing
Tuaillon, É., Mondain, A., Meroueh, F., Ottomani, L., Picot, M., Nagot, N., de Perre, P. V., & Ducos, J. (2009) · Hepatology · doi:10.1002/hep.23407 · Cited by 142
Beste, L. A., Green, P. K., Berry, K., Kogut, M. J., Allison, S. K., & Ioannou, G. N. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.02.027 · Cited by 142
Mahale, P. S., Engels, E. A., Li, R., Torres, H. A., Hwang, L., Brown, E. L., & Kramer, J. R. (2017) · Gut · doi:10.1136/gutjnl-2017-313983 · Cited by 139
Deterding, K., Spinner, C. D., Schott, E., Welzel, T. M., Gerken, G., Klinker, H., Spengler, U., Wiegand, J., Wiesch, J. S. Z., Pathil, A., et al. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(16)30408-x · Cited by 129
Self-citationClinical outcomes of patients undergoing antiviral therapy while awaiting liver transplantation
Pascasio, J. M., Vinaixa, C., Ferrer, M. T., Colmenero, J., Rubín, Á., Castells, L., Manzano, M. L., Lorente, S., Testillano, M., Xiol, X., et al. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.08.008 · Cited by 129
Hepatocellular Carcinoma in 2 Young Adolescents With Chronic Hepatitis C
González‐Peralta, R. P., Langham, M. R., Andres, J. M., Mohan, P., Colombani, P. M., Alford, M. K., & Schwarz, K. B. (2009) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0b013e318170af04 · Cited by 127
Norton, B. L., Fleming, J. G., Bachhuber, M. A., Steinman, M., DeLuca, J., Cunningham, C. O., Johnson, N., Laraque, F., & Litwin, A. H. (2017) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2017.07.021 · Cited by 126
Bruno, S., Marco, V. D., Iavarone, M. A., Roffi, L., Crosignani, A., Calvaruso, V., Aghemo, A., Cabibbo, G., Viganò, M., Boccaccio, V., et al. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.01.034 · Cited by 123
Self-citationEfficacy of Ledipasvir and Sofosbuvir Treatment of HCV Infection in Patients Coinfected With HBV
Liu, C., Chuang, W., Sheen, I., Wang, H., Chen, C.-Y., Tseng, K., Chang, T., Massetto, B., Yang, J. C., Yun, C., et al. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.11.011 · Cited by 117
Vermehren, J., Kau, A., Gärtner, B. C., Göbel, R., Zeuzem, S., & Sarrazin, C. (2008) · Journal of Clinical Microbiology · doi:10.1128/jcm.00755-08 · Cited by 116
Mason, K., Dodd, Z., Guyton, M., Tookey, P., Lettner, B., Matelski, J. J., Sockalingam, S., Altenberg, J., & Powis, J. E. (2017) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2017.05.025 · Cited by 116
Innes, H. A., Barclay, S. T., Hayes, P. C., Fraser, A. G., Dillon, J. F., Stanley, A. J., Bathgate, A., McDonald, S., Goldberg, D. J., Valerio, H., et al. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.10.033 · Cited by 111
Mixed HCV infection and reinfection in people who inject drugs—impact on therapy
Cunningham, E. B., Applegate, T. L., Lloyd, A. R., Dore, G. J., & Grebely, J. (2015) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2015.36 · Cited by 105
Wirth, S., Rosenthal, P. J., González‐Peralta, R. P., Jonas, M. M., Balistreri, W. F., Lin, C., Hardikar, W., Kersey, K., Massetto, B., Kanwar, B., et al. (2017) · Hepatology · doi:10.1002/hep.29278 · Cited by 105
Grebely, J., Mauss, S., Brown, A. S., Bronowicki, J., Puoti, M., Wyles, D. L., Natha, M., Zhu, Y., Yang, J., Kreter, B., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw580 · Cited by 98
Self-citationHepatitis C Virus Reinfection Following Treatment Among People Who Use Drugs
Grady, B. P. X., Schinkel, J., Thomas, X. V., & Dalgård, O. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit301 · Cited by 97
Deterding, K., Grüner, N. H., Buggisch, P., Wiegand, J., Galle, P. R., Spengler, U., Hinrichsen, H. M., Berg, T., Potthoff, A., Malek, N. P., et al. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70059-8 · Cited by 96
Self-citationHuang, A. C., Mehta, N. J., Dodge, J. L., Yao, F. Y., & Terrault, N. A. (2018) · Hepatology · doi:10.1002/hep.29855 · Cited by 96
Khuroo, M. S., Khuroo, M. S., & Khuroo, M. S. (2015) · PLoS ONE · doi:10.1371/journal.pone.0121450 · Cited by 92
Factors associated with spontaneous clearance of chronic hepatitis C virus infection
Bulteel, N., Sarathy, P. P., Forrest, E. H., Stanley, A. J., Innes, H. A., Mills, P. R., Valerio, H., Gunson, R. N., Aitken, C., Morris, J., et al. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.04.030 · Cited by 91
Diagnosis and management of chronic viral hepatitis: Antigens, antibodies and viral genomes
Chevaliez, S., & Pawlotsky, J. (2008) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2008.11.004 · Cited by 89
Self-citationOptimal timing of hepatitis C treatment for patients on the liver transplant waiting list
Chhatwal, J., Samur, S., Kues, B., Ayer, T., Roberts, M. S., Kanwal, F., Hur, C., Donnell, D. M. S., & Chung, R. T. (2016) · Hepatology · doi:10.1002/hep.28926 · Cited by 88
Fraser, H., Zibbell, J. E., Hoerger, T. J., Hariri, S., Vellozzi, C. J., Martin, N. K., Kral, A. H., Hickman, M., Ward, J. W., & Vickerman, P. T. (2017) · Addiction · doi:10.1111/add.13948 · Cited by 87
Direct antiviral agents and risk for HCC early recurrence: Much ado about nothing
Cammà, C., Cabibbo, G., & Craxì, A. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.04.033 · Cited by 86
Rockstroh, J. K., Bhagani, S., Hyland, R. H., Yun, C., Dvory‐Sobol, H., Zheng, W., Brainard, D. M., Ingiliz, P., Lutz, T., Boesecke, C., et al. (2017) · The Lancet. Gastroenterology & hepatology · doi:10.1016/s2468-1253(17)30003-1 · Cited by 85
Reinfection with hepatitis C virus following sustained virological response in injection drug users
Grebely, J., Knight, E., Ngai, T., Genoway, K. A., Raffa, J. D., Storms, M. M., Gallagher, L., Krajden, M., Dore, G. J., Duncan, F., et al. (2009) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2010.06238.x · Cited by 82
Torres, H. A., Vauthey, J., Economides, M. P., Mahale, P. S., & Kaseb, A. O. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.05.034 · Cited by 81
Bruchfeld, A. N., Roth, D., Martin, P. B., Nelson, D. R., Pol, S., Londoño, M., Monsour, H., Silva, M., Hwang, P. M. T., Arduino, J. M., et al. (2017) · The Lancet. Gastroenterology & hepatology · doi:10.1016/s2468-1253(17)30116-4 · Cited by 81
Interferon as treatment for acute hepatitis C
Cammà, C., Almasio, P. L., & Craxı̀, A. (1996) · Digestive Diseases and Sciences · doi:10.1007/bf02088245 · Cited by 79
Petta, S., Cabibbo, G., Barbàra, M., Attardo, S., Bucci, L., Farinati, F., Giannini, E. G., Tovoli, F., Ciccarese, F., Rapaccini, G. L., et al. (2016) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13821 · Cited by 79
Self-citationDarke, S. G., Kaye, S. S., & Duflou, J. A. (2006) · Addiction · doi:10.1111/j.1360-0443.2006.01601.x · Cited by 77
Acute hepatitis C: diagnosis and management
Mondelli, M. U., Cerino, A., & Cividini, A. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2004.10.017 · Cited by 76
Siu, L., Foont, J., & Wands, J. (2009) · Seminars in Liver Disease · doi:10.1055/s-0029-1214374 · Cited by 74 · cited 1×
“Hepatitis C patients with on-going alcohol consumption during treatment profit from additional support during antiviral therapy [50-53].”
Virlogeux, V., Pradat, P., Hartig-Lavie, K., Bailly, F., Maynard, M., Ouziel, G., Erard‐Poinsot, D., Lebossé, F., Ecochard, M., Radenne, S., et al. (2017) · Liver International · doi:10.1111/liv.13456 · Cited by 74
Lai, T., Lee, M., Yang, H., You, S., Lu, S., Wang, L., Yuan, Y., L’Italien, G., Chien, K., Chen, C., et al. (2017) · Hepatology · doi:10.1002/hep.29192 · Cited by 73
Bruneau, J., Zang, G., Abrahamowicz, M., Jutras‐Aswad, D., Daniel, M., & Roy, É. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit938 · Cited by 72
Tsui, J. I., Williams, E. C., Green, P. K., Berry, K., Su, F., & Ioannou, G. N. (2016) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2016.10.021 · Cited by 69
Bang, C. S., & Song, I. H. (2017) · BMC Gastroenterology · doi:10.1186/s12876-017-0606-9 · Cited by 67
Currie, S. L., Ryan, J. C., Tracy, D., Wright, T. L., George, S., McQuaid, R., Kim, M., Shen, H., & Monto, A. (2007) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2007.09.011 · Cited by 63
Grebely, J., Raffa, J., Lai, C., Kerr, T., Fischer, B., Krajden, M., Dore, G., & Tyndall, M. (2011) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2010.01279.x · Cited by 60
Kowdley, K. V., Sundaram, V., Jeon, C. Y., Qureshi, K., Latt, N. L., Sahota, A. K., Lott, S. A., Curry, M. P., Tsai, N. C. S., Chaiyakunapruk, N., et al. (2016) · Hepatology · doi:10.1002/hep.29005 · Cited by 59
Wedemeyer, H. H., Craxì, A., Zuckerman, E., Dieterich, D. T., Flisiak, R., Roberts, S. K., Pangerl, A., Zhang, Z., Martínez, M., Bao, Y., et al. (2017) · Journal of Viral Hepatitis · doi:10.1111/jvh.12722 · Cited by 57
Self-citationReau, N. S., Kwo, P. Y., Rhee, S. M., Brown, R. S., Agarwal, K., Angus, P. W., Gane, E. J., Kao, J., Mantry, P., Reddy, K. R., et al. (2017) · Journal of Hepatology · doi:10.1016/s0168-8278(17)30444-0 · Cited by 56
Severe Pulmonary Arterial Hypertension in Patients Treated for Hepatitis C With Sofosbuvir
Renard, S., Borentain, P., Salaün, E., Benhaourech, S., Maille, B., Darque, A., Brégigeon, S., Colson, P., Laugier, D., Reynaud‐Gaubert, M., et al. (2016) · CHEST Journal · doi:10.1016/j.chest.2015.09.018 · Cited by 55
Martinello, M., Gane, E. J., Hellard, M. E., Sasadeusz, J. J., Shaw, D., Petoumenos, K., Applegate, T. L., Grebely, J., Maire, L., Marks, P. S., et al. (2016) · Hepatology · doi:10.1002/hep.28844 · Cited by 54
Ticehurst, J. R., Hamzeh, F. M., & Thomas, D. L. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.02448-06 · Cited by 51
Larney, S., Grebely, J., Hickman, M., de Angelis, D. D., Dore, G., & Degenhardt, L. (2015) · The International journal on drug policy · doi:10.1016/j.drugpo.2015.07.010 · Cited by 51
Bruggmann, P., Dampz, M., Gerlach, T., Kravecz, L., & Falcato, L. (2010) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2010.02.016 · Cited by 50
Virologic Tools for HCV Drug Resistance Testing
Fourati, S., & Pawlotsky, J. (2015) · Viruses · doi:10.3390/v7122941 · Cited by 49
Self-citationOriga, R., Ponti, M. L., Filosa, A., Lanza, A. G., Piga, A. G., Saracco, G. M., Pinto, V. M., Picciotto, A., Rigano, P., Madonia, S., et al. (2017) · American Journal of Hematology · doi:10.1002/ajh.24911 · Cited by 49
Welzel, T. M., Asselah, T., Dumas, E. O., Zeuzem, S., Shaw, D., Hazzan, R., Forns, X., Pilot-Matias, T., Lu, W., Cohen, D. E., et al. (2017) · The Lancet. Gastroenterology & hepatology · doi:10.1016/s2468-1253(17)30071-7 · Cited by 48
Interferon for acute hepatitis C
Myers, R. P., Regimbeau, C., Thévenot, T., Leroy, V., Mathurin, P., Opolon, P., Zarski, J., & Poynard, T. (2001) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000369 · Cited by 45
Moon, C., Jung, K. S., Kim, D. Y., Baatarkhuu, O., Park, J. Y., Kim, B. K., Kim, S. U., Ahn, S. H., & Han, K. (2014) · Digestive Diseases and Sciences · doi:10.1007/s10620-014-3361-6 · Cited by 42
Foster, G. R., Gane, E. J., Asatryan, A., Asselah, T., Ruane, P. J., Pol, S., Poordad, F. F., Stedman, C. A. M., Dore, G. J., Roberts, S., et al. (2017) · Journal of Hepatology · doi:10.1016/s0168-8278(17)30326-4 · Cited by 40
Lan, C. L., Guillygomarc’h, A., Danielou, H., Dréau, G. L., Lainé, F., Vedeilhie, C., Deugnier, Y., Brissot, P., Guyader, D., & Moirand, R. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2011.05.021 · Cited by 35
Krishnan, P., Schnell, G., Tripathi, R. L., Ng, T., Reisch, T., Beyer, J. M., Dekhtyar, T., Irvin, M., Xie, W., Larsen, L. M., et al. (2017) · Journal of Hepatology · doi:10.1016/s0168-8278(17)31399-5 · Cited by 34
Rodis, J. L., & Kibbe, P. J. (2010) · Gastroenterology Nursing · doi:10.1097/sga.0b013e3181f443cb · Cited by 31
The use of generic medications for hepatitis C
Freeman, J. A., & Hill, A. M. (2016) · Liver International · doi:10.1111/liv.13157 · Cited by 31
Younossi, Z. M. (2017) · Clinics in Liver Disease · doi:10.1016/j.cld.2017.03.001 · Cited by 31
Cortesi, P. A., Belli, L. S., Facchetti, R., Mazzarelli, C., Perricone, G., Nicola, S. D., Cesana, G., Duvoux, C., Mantovani, L. G., & Strazzabosco, M. (2018) · Journal of Viral Hepatitis · doi:10.1111/jvh.12877 · Cited by 31
Interaction between hepatitis B and C viruses in hepatocellular carcinogenesis
Kew, M. C. (2006) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2005.00686.x · Cited by 24
Cited by
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
Galle, P. R., Forner, A., Llovet, J. M., Mazzaferro, V., Piscaglia, F., Raoul, J.-L., Schirmacher, P., & Vilgrain, V. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.03.019 · Cited by 11,406
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
Lampertico, P., Agarwal, K., Berg, T., Buti, M., Janssen, H. L. A., Papatheodoridis, G., Zoulim, F., & Tacke, F. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.03.021 · Cited by 5,391
Kaminski, M. M., Abudayyeh, O. O., Gootenberg, J. S., Zhang, F., & Collins, J. J. (2021) · Nature Biomedical Engineering · doi:10.1038/s41551-021-00760-7 · Cited by 1,259
EASL recommendations on treatment of hepatitis C: Final update of the series☆
Pawlotsky, J.-M., Negro, F., Aghemo, A., Berenguer, M., Dalgard, O., Dusheiko, G., Marra, F., Puoti, M., & Wedemeyer, H. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.08.018 · Cited by 1,252
Self-citationReig, M., Mariño, Z., Perelló, C., Iñarrairaegui, M., Ribeiro, A., Lens, S., Díaz, A., Vilana, R., Darnell, A., Varela, M., et al. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.04.008 · Cited by 1,018
Metadata
- Authors
- Pawlotsky, J.-M., Negro, F., Aghemo, A., Berenguer, M., Dalgard, O., Dusheiko, G., Marra, F., Puoti, M., & Wedemeyer, H.
- Venue
- Journal of Hepatology
- Publisher
- Elsevier BV
- Published
- 2018-08
- Volume
- 69
- Issue
- 2
- Pages
- 461-511
- ISSN
- 0168-8278 (ISSN-L)
- OpenAlex
- W2185218296
- Cited by
- 2,827
- References
- 204
- FWCI
- 222.94
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.